Microglial activation drives neuroinflammation, a key factor in many neurological diseases. The purinergic system is a major regulator of inflammatory responses and represents a promising target for controlling neuroinflammation. Capsaicin, a bioactive compound found in chili peppers, exhibits significant anti-inflammatory and antioxidant properties. This study aimed to investigate the modulatory effects of capsaicin on microglial activation and purinergic system regulation. For this, BV-2 microglial cells were exposed to lipopolysaccharide (1 μg/mL) and treated with capsaicin (25 and 50 μM) for 24 hours. Cell viability was assessed by MTT and trypan blue assays. Cell cycle and apoptosis were evaluated by flow cytometry. Nitric oxide, reactive species and malondialdehyde levels were evaluated as markers of oxidative stress. Activities of NTPDase, 5'-nucleotidase (5’-NT), and adenosine deaminase (ADA) were evaluated. Gene expression of inflammatory mediators and purinergic receptors were analyzed by qRT-PCR, and molecular docking analyses were performed. As a result, capsaicin decreased the expression of pro-inflammatory mediators (NLRP3, CASP-1, IL-1β, IL-6, and TNF-α), increased IL-10 expression, and attenuated oxidative stress. It reduced NTPDase, 5'-NT, and ADA activities, downregulated P2X7 and A2A receptor expression, and upregulated A1 receptor expression. Molecular docking revealed that capsaicin has a high affinity for the A1 and A2A receptors, as well as for ADA. Collectively, these findings suggest that capsaicin exerts neuroprotective effect by suppressing pro-inflammatory signaling, enhancing anti-inflammatory responses, reducing oxidative stress, and modulating key components of the purinergic system, including ectoenzyme activities and P2X7, A1, and A2A receptor expression. Graphical Abstract Lipopolysaccharide (LPS) activates microglia via the NLRP3 pathway, increasing pro-inflammatory cytokines, purinergic receptors expression (P2X7 and A2A), and the activity of CD39, CD73, and ADA. Capsaicin mitigates this inflammatory profile by inhibiting NLRP3 signaling, reducing pro-inflammatory cytokine expression and modulating purinergic signaling toward an anti-inflammatory profile. Illustrations were obtained from Servier Medical Art ( https://smart.servier.com/ ), licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).

Cancer is an important cause of lethality, and melanoma is associated with less than 10% of survival. The traditional treatment includes the use of vinblastine, and it is associated with side effects. Curcumin is extracted from Curcuma longa rhizomes, and studied in many diseases, producing a variety of effects. We investigated the role of various cellular pathways concerning apoptosis, cell cycle enzymes in melanoma cell line SK-MEL-28, after treatment with curcumin, vinblastine, or a combination of both, for 24 hours. After this, we performed cell cycle, apoptosis, wound healing assay, comet assay on cells, and evaluated nitrite accumulation (nitric oxide (NO•) byproduct). Curcumin increased cells in apoptosis and reduced the number of cells in the G1 phase. Vinblastine increased the production of nitrite, and cells in early apoptosis, mainly through the inducement of DNA damage. Cell migration was impaired in all tested groups. In conclusion, curcumin impaired migration, producing NO•, and promoting apoptosis of tumoral cells. Vinblastine also impaired cell migration and increased levels of NO•. Curcumin might be included as an adjuvant in the treatment of melanoma, and help treatment of melanoma, and further studies are needed, especially regarding the synergistic effect of curcumin and vinblastine in the treatment.

Background/Objectives: Major depressive disorder (MDD) is a debilitating illness, and chronic stress is a contributing factor for depressive symptoms. However, despite intense research, the mechanisms of MDD remain substantially unidentified. Quercetin is a powerful flavonoid and could be used as a possible therapeutic strategy for depression. Acknowledging the potential benefits of quercetin, this study investigated its effect alone or in association with the standard drug tranylcypromine (TCP) in a rodent model of chronic restraint stress (CRS). Methods: Adult male rats were subjected to a CRS model consisting of an immobilization session of 4 h daily during 14 consecutive days. Quercetin (50 mg/kg, gavage) was administered for 45 days. TCP (10 mg/kg, gavage) was administered for 14 days. Behavioral tasks were conducted to assess locomotor functions, memory, anhedonia, depression-like behaviors, and anxiety-like behaviors. The activity, gene expression, and protein density of acetylcholinesterase (AChE) were investigated. Results: Behavioral tasks showed that the CRS model effectively induced stable behavioral changes. CRS did not alter locomotor function assessed by the open field test (OFT) or anhedonia behavior assessed by the sucrose preference test (SPT). CRS increased total fecal count, which was prevented by quercetin administration in rats. TCP and the association of quercetin and TCP increased the recognition index in comparison with the CRS group in the novel object recognition (NOR) test and improved the swimming and immobility times in comparison to stressed animals in the forced swim test (FST). All treatments were able to decrease the anxiety index assessed by the elevated plus maze (EPM) test. The activity, gene expression, and protein density of AChE were increased in the CRS model compared to control males. Overall, quercetin and TCP proved to reverse CRS-induced alterations in these parameters. Conclusions: Quercetin mitigated cognitive deficits, behavioral impairments, and neurochemical alterations induced by the CRS model, especially in association with TCP, supporting its potential as a promising therapeutic agent for depression.